AGC to Establish New Production Site for Pharmaceutical Intermediates

AGC (Asahi Glass Co., Ltd.; Head Office: Tokyo; President & CEO: Kazuhiko Ishimura) announced that it will establish a new production site for pharmaceutical and agrochemical intermediates and active ingredients at its subsidiary, AGC Wakasa Chemicals Co., Ltd. (hereafter, "AGC Wakasa Chemicals").

AGC will invest 3.7 billion yen in the new plant scheduled to start operation around November 2012. This will approximately double the current production capacity for pharmaceutical and agrochemical intermediates and active ingredients, and contribute to the AGC Group´s aim to achieve net sales of 15 billion yen or more in this business segment in 2014.

As the elderly population grows in developed countries and the world faces food supply issues in conjunction with the worldwide population increase, demand for pharmaceuticals and agrochemicals is expected to continue growing. Hence the demand for intermediates and active ingredients used in the production of pharmaceuticals and agrochemicals is also projected to rise. The AGC Group has been making use of its strength in fluorine chemical technology in providing fluorinated compounds as well as other pharmaceutical and agrochemical intermediates and active ingredients to date, and will further reinforce the Group´s production capacity to accommodate the expected growth in demand.

The new plant profiled below will be the AGC Group´s fourth production site for pharmaceutical and agrochemical intermediates and active ingredients:

Location: Wakasa Techno Valley, Wakasa-cho, Mikatakaminaka-gun, Fukui prefecture Area: 28,400 square meters Items produced: Pharmaceutical and agrochemical intermediates and active ingredients Production facility: Total Capacity of chemical reactors: 140 cubic meters Number of employees: Approximately 20 AGC contributes to enriching people´s living through making use of the fluorine chemical technology cultivated over many years to offer distinguished products also in the area of pharmaceutical and agrochemical intermediates and active ingredients.

Read the full article below.

600450 AGC to Establish New Production Site for Pharmaceutical Intermediates glassonweb.com

See more news about:

Others also read

On September 24th, Peng Shou, president of China National Building Material Co., Ltd. and board chairman of Triumph Technology Group Company, held friendly talks with Takuya Shimamura, president of AGC Inc.(former Asahi Glass Co.), during his visit to Japan for attending the ICG Annual Meeting 2018.
New products promoting originality in architecture and interiors.
Working with Hasker Architects and AGC Glass, Euroview supplied exceptionally flat glass for a contemporary facade office extension to a listed building.
AGC Asahi Glass announces that it has started the construction of a net zero-energy building (ZEB*1) at its Kashima Plant.
AGC and Kinestral Technologies announced the creation of three joint venture companies that will sell, distribute, and service Halio to the global market.
New Low-Iron Glass Offers Unparalleled Light Transmission and Color Optimization.

Add new comment